Target intelligence / Profile preview

Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1)

Target
KNDC1
Molecular classification
Other, Ras guanine nucleotide exchange factor (Ras-GEF) family–related, protein-protein interaction module
01

Overview

Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1) is a protein found mainly in neuronal and endothelial cells and is involved in regulating signal transduction pathways including the p53 and MAPK pathways. KNDC1 serves as a scaffold or protein-protein interaction module rather than a catalytic kinase; it is implicated in processes such as cellular senescence, cell proliferation, dendritic development in neurons, and angiogenesis. Knockdown of KNDC1 in endothelial cells promotes proliferation, delays senescence, and enhances tube formation by affecting the p53-p21-p16 pathway and ERK signaling, while overexpression accelerates senescence via a p53–reactive oxygen species positive feedback loop[1][2]. KNDC1 is considered a candidate therapeutic target for modulating cellular aging and possibly for treating age-related vascular or neuronal diseases. No direct pharmacological agents or biomarkers specific to KNDC1 are currently established in the literature.

Other names
KNDC1C10orf23KIAA1768RASGEF2VKINDKIND domain-containing protein 1v-KINDCerebral protein 9Very-KINDProtein very KINDRas-GEF domain-containing family member 2RasGEF domain family, member 2kinase non-catalytic C-lobe domain containing 1bB439H18.3FLJ25027
02

Mechanism of action

Modulation of p53 signaling pathway (senescence induction), Regulation of MAPK (ERK) pathway for cell proliferation, p53–ROS positive feedback loop activation

03

Biological functions

Regulation of cellular senescenceSignal transductionRegulation of cell proliferationRegulation of neuronal dendrite developmentModulation of angiogenesis
04

Disease associations

Cardiovascular disease (via vascular endothelial cell senescence)Neurodegenerative disease (neuronal dendrite development)Potential aging-related disorders
05

Safety considerations

Potentially broad impact on endothelial and neuronal cell function if modulatedrisk of altered angiogenesis or neural development if targeted systemically

Beyond the preview

Go deeper on Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinase non-catalytic C-lobe domain-containing protein 1 (KNDC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call